Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • C-terminal-truncating ASXL1 mutations induce MDS via inhibition of PRC2
    Meeting Abstract

    Inoue, D.; Kitaura, J.; Togami, K.; Nishimura, K.; Enomoto, Y.; Uchida, T.; Kagiyama, Y.; Kawabata, K. C.; Nakahara, F.; Oki, T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of markers of thrombotic risk and response to cytoreductive intervention In Philadelphia-chromosome negative myeloproliferative neoplams
    Meeting Abstract

    Hobbs, G. S.; Patel, M.; Chung, Y. R.; Abdel-Wahab, O.; Soff, G. A.; Rampal, R. K.
    Blood (2013)

    Fulltext@MSK | Save
  • Mutational profiling of myeloid malignancies for prediction of disease relapse following allogeneic stem cell transplantation
    Meeting Abstract

    Hanash, A. M.; Devlin, S. M.; Maloy, M.; Knapp, K. M.; Miller, V. A.; Lipson, D.; Stephens, P. J.; Otto, G. A.; Yelensky, R.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Durable responses and improved quality of life with midostaurin (PKC412) in advanced systemic mastocytosis (SM): Updated stage 1 results of the global D2201 trial
    Meeting Abstract

    Gotlib, J.; Kluin-Nelemans, H. C.; George, T. I.; Akin, C.; Sotlar, K.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Morariu, R.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Therapeutic efficacy and cure of sensitive and T315I pan-resistant human Ph+ leukemia in mice using a TCR-like antibody to WT1/HLA-A0201 alone, or in combination with tyrosine kinase inhibitors
    Meeting Abstract

    Dubrovsky, L.; Brea, E.; Pankov, D.; Veomett, N.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Results of a phase 2 randomized, open-label, study of lower doses of quizartinib (AC220; ASP2689) in subjects with FLT3-ITD positive relapsed or refractory acute myeloid leukemia (AML)
    Meeting Abstract

    Cortes, J. E.; Tallman, M. S.; Schiller, G.; Trone, D.; Gammon, G.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Levis, M.
    Blood (2013)

    Fulltext@MSK | Save
  • High-grade pegylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles
    Meeting Abstract

    Burke, P. W.; Aldoss, I.; Lunning, M. A.; Avramis, V. I.; Mohrbacher, A. M.; Pullarkat, V.; Tallman, M. S.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save